Advertisement

Osteoporosis International

, Volume 30, Issue 3, pp 703–703 | Cite as

Correction to: Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials?

  • K.L. OngEmail author
  • D.P. Beall
  • M. Frohbergh
  • E. Lau
  • J.A. Hirsch
Correction
  • 277 Downloads

Correction to: Osteoporosis International

  https://doi.org/10.1007/s00198-017-4281-z

The article Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials?, written by K. L. Ong, D. P. Beall, M. Frohbergh, E. Lau, and J. A. Hirsch was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 24 October 2017 without open access.

With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 6 February 2019 to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The original article has been corrected.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Notes

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • K.L. Ong
    • 1
    Email author
  • D.P. Beall
    • 2
  • M. Frohbergh
    • 1
  • E. Lau
    • 3
  • J.A. Hirsch
    • 4
  1. 1.Exponent, Inc.PhiladelphiaUSA
  2. 2.Oklahoma SpineEdmondUSA
  3. 3.Exponent, Inc.Menlo ParkUSA
  4. 4.Massachusetts General HospitalBostonUSA

Personalised recommendations